Center for Clinical and Translational Science (OSU)

The Ohio State University Center for Clinical and Translational Science (OSU CCTS) is a collaboration among the University, The Ohio State University Wexner Medical Center and Nationwide Children's Hospital dedicated to turning the scientific discoveries of today into life-changing disease prevention strategies and the health diagnostics and treatments of tomorrow.

Funded by a multi-year Clinical and Translational Science Award (CTSA) from the National Institutes of Health, the OSU CCTS leverages expertise from all participants, community health and education agencies, business partnerships, and regional institutional network partnerships.


  • Director: Rebecca D. Jackson, MD (The Ohio State University College of Medicine)
  • Pediatric Director: William E. Smoyer, MD (Center for Clinical and Translational Research, the Abigail Wexner Research Institute at Nationwide Children's Hospital)
  • Co-Director for Clinical Research Resources: Cynthia A. Gerhardt, PhD (Center for Biobehavioral Health, the Abigail Wexner Research Institute at Nationwide Children's Hospital)


In 2008, the NIH awarded a $34-million, five-year CTSA grant to The Ohio State University – along with Nationwide Children’s Hospital – to fund the CCTS. Among the largest research grants in the University’s history, the CTSA award was a team effort based on the clinical and translational research enterprise, training programs, informatics capabilities, trans-disciplinary collaborations and partnerships with private and public organizations. In 2013, the NIH awarded a $25.4 million grant to the CCTS to continue accelerating basic science discoveries into life-saving medical advances.

“Both the Ohio State and Nationwide Children’s campuses have dedicated substantial resources and infrastructure to grow our translational research capabilities," said John Barnard, MD, president of the Abigail Wexner Research Institute at Nationwide Children’s. “This investment has delivered some major breakthroughs, particularly with gene therapy for some of the most deadly and debilitating muscular diseases. Our partnership is giving us new insights in the continuum of care as children with chronic disease grow into adults, and offering new possibilities for preventing disease altogether.”

Core Services at Nationwide Children's Hospital

Relevant Links